Immune Checkpoint Inhibitors in Head and Neck Cancer: Understanding the Current Evidence and Future Directions

Download All

Download slidesets and review an archived webcast from a live symposium in which 3 experts discussed the rationale for checkpoint inhibition in advanced HNSCC, provided practical guidance on clinical use, and assessed promising near-future immunotherapies for HNSCC. Review key points for HNSCC treatment with a downloadable resource guide.

Barbara Burtness, MD
Program Director
Robert L. Ferris, MD, PhD
Cristina P. Rodriguez, MD

On-Demand Webcast

In this archived CME-certified symposium Webcast, 3 experts on head and neck cancers examine the rationale for using checkpoint inhibitors in advanced HNSCC, provide practical guidance for their clinical use, and discuss promising near-future immunotherapies for HNSCC.

Barbara Burtness, MD
Program Director
Robert L. Ferris, MD, PhD Cristina P. Rodriguez, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: August 8, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings